Rituximab as First Choice for Patients With Refractory Rheumatoid Arthritis- Cost-Effectiveness Analysis in Iran Based on A Systematic Review and Meta-Analysis
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2623
https://www.valueinhealthjournal.com/article/S1098-3015(14)04572-0/fulltext
Title :
Rituximab as First Choice for Patients With Refractory Rheumatoid Arthritis- Cost-Effectiveness Analysis in Iran Based on A Systematic Review and Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04572-0&doi=10.1016/j.jval.2014.08.2623
First page :
A382
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
329